- Home
- SCYX vs LTBR Comparison
SCYX vs LTBR Comparison
Compare SCYX & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- LTBR
- Stock Information
- Founded
- SCYX 1999
- LTBR 1992
- Country
- SCYX United States
- LTBR United States
- Employees
- SCYX N/A
- LTBR N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- LTBR Professional Services
- Sector
- SCYX Health Care
- LTBR Consumer Discretionary
- Exchange
- SCYX Nasdaq
- LTBR Nasdaq
- Market Cap
- SCYX 50.3M
- LTBR 45.5M
- IPO Year
- SCYX 2014
- LTBR N/A
- Fundamental
- Price
- SCYX $1.02
- LTBR $5.64
- Analyst Decision
- SCYX Buy
- LTBR
- Analyst Count
- SCYX 1
- LTBR 0
- Target Price
- SCYX N/A
- LTBR N/A
- AVG Volume (30 Days)
- SCYX 210.1K
- LTBR 867.3K
- Earning Date
- SCYX 11-06-2024
- LTBR 10-31-2024
- Dividend Yield
- SCYX N/A
- LTBR N/A
- EPS Growth
- SCYX N/A
- LTBR N/A
- EPS
- SCYX N/A
- LTBR N/A
- Revenue
- SCYX $8,566,000.00
- LTBR N/A
- Revenue This Year
- SCYX N/A
- LTBR N/A
- Revenue Next Year
- SCYX $405.82
- LTBR N/A
- P/E Ratio
- SCYX N/A
- LTBR N/A
- Revenue Growth
- SCYX N/A
- LTBR N/A
- 52 Week Low
- SCYX $0.90
- LTBR $2.21
- 52 Week High
- SCYX $3.07
- LTBR $14.20
- Technical
- Relative Strength Index (RSI)
- SCYX 34.82
- LTBR 51.18
- Support Level
- SCYX $0.90
- LTBR $4.37
- Resistance Level
- SCYX $1.04
- LTBR $5.50
- Average True Range (ATR)
- SCYX 0.07
- LTBR 0.55
- MACD
- SCYX -0.01
- LTBR 0.05
- Stochastic Oscillator
- SCYX 34.10
- LTBR 68.65
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through Nuclear Fuel Technology segment. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.